First Day Closed at HK$5.36 HONG KONG, July 12, 2022 /PRNewswire/ With a leading position in the medical products and channels segment, mainly providing healthcare insight solutions via offline channels to address the sales and marketing needs of the medical product manufacturer clients. - Sinohealth Holdings Limited ("Sinohealth Holdings" or the "Company", stock code: 2361.HK, together with its subsidiaries, collectively as the "Group"), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange"or "HKEX") today, under the stock code of 2361 and in board lot of 500 shares each. The share price of the Company closed at HK$5.36 per share. A total of approximately 21.54 million shares were traded, with an aggregate turnover of approximately HK$111million. Sinohealth Holdings is listed on the main board of HKEX, with 75,000,000shares being offered globally, includ
Offer Price Between HK$5.36 and HK$6.96 per Share To Raise Proceeds Up to HK$522 million The Largest Provider of Healthcare Insight Solutions for Medical Products and Channels in China HONG KONG, June 28, 2022 /PRNewswire/ A leading healthcare insight solutions provider in China - Sinohealth Holdings Limited ("Sinohealth Holdings" or the "Company", stock code: 2361.HK, together with its subsidiaries, collectively as the "Group"), today announced the proposed listing of its Shares on the Main Board of Hong Kong Exchanges and Clearing Limited ("Hong Kong Stock Exchange"). Sinohealth Holdings plans to offer 75,000,000 Shares (subject to the Over-allotment Option), of which 67,500,000 Shares will be International Placing Shares (subject to reallocation and the Over-allotment Option), representing 90% of the initial Offer Shares; the remaining 7,500,000 Shares will be Hong Kong Offer Shares (subject to reallocation), representing 10% of the initial